General Information of the Compound
| Compound ID |
CP0385856
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
6-cyclopropyl-1-(2,4-dichlorophenyl)-N-[(1S,2R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl]-4H-indeno[1,2-c]pyrazole-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H31Cl2N3O
|
||||||||||||||||||
| Molecular Weight |
520.504
|
||||||||||||||||||
| Canonical SMILES |
CC1(C)[C@@H]2CC[C@]1(C)[C@@H](C2)NC(=O)c1nn(c-2c1Cc1cc(ccc-21)C1CC1)-c1ccc(Cl)cc1Cl
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H31Cl2N3O/c1-29(2)19-10-11-30(29,3)25(14-19)33-28(36)26-22-13-18-12-17(16-4-5-16)6-8-21(18)27(22)35(34-26)24-9-7-20(31)15-23(24)32/h6-9,12,15-16,19,25H,4-5,10-11,13-14H2,1-3H3,(H,33,36)/t19-,25-,30-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
XIUWBZFDKMJYGN-QMNWOKLKSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01298, Cannabinoid receptor 1
Protein ID: PT00834, Cannabinoid receptor 2